Nuveen Asset Management’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-74,190
| Closed | -$1.05M | – | 3413 |
|
|
2024
Q1 | $1.05M | Buy |
74,190
+3,390
| +5% | +$48.1K | ﹤0.01% | 2683 |
|
|
2023
Q4 | $1.01M | Buy |
70,800
+69,868
| +7,497% | +$997K | ﹤0.01% | 2732 |
|
|
2023
Q3 | $14.4K | Buy |
+932
| New | +$14.4K | ﹤0.01% | 3180 |
|
|
2022
Q1 | – | Sell |
-583,493
| Closed | -$7.95M | – | 3328 |
|
|
2021
Q4 | $7.95M | Sell |
583,493
-1,320,181
| -69% | -$18M | ﹤0.01% | 1826 |
|
|
2021
Q3 | $31.2M | Sell |
1,903,674
-31,391
| -2% | -$514K | 0.01% | 964 |
|
|
2021
Q2 | $32.6M | Buy |
1,935,065
+247,697
| +15% | +$4.17M | 0.01% | 1010 |
|
|
2021
Q1 | $30.8M | Buy |
1,687,368
+462,051
| +38% | +$8.44M | 0.01% | 1015 |
|
|
2020
Q4 | $22.3M | Buy |
+1,225,317
| New | +$22.3M | 0.01% | 1194 |
|
|
2020
Q1 | – | Sell |
-67,708
| Closed | -$1.34M | – | 3167 |
|
|
2019
Q4 | $1.34M | Hold |
67,708
| – | – | ﹤0.01% | 2583 |
|
|
2019
Q3 | $1.17M | Hold |
67,708
| – | – | ﹤0.01% | 2632 |
|
|
2019
Q2 | $1.2M | Buy |
+67,708
| New | +$1.2M | ﹤0.01% | 2661 |
|